Differential diagnosis of high-grade astrocytic gliomas based on CD44, SOX2, and CIRBP gene expression analysis
Original method based on marker gene expression ratios does not replace standard diagnostic protocols, but may be an additional tool for optimized diagnostic process. This approach will be valuable to minimize errors and personalize therapeutic strategies. The last one is critical for prognosis.
Authors
- Ya. A. Sliman
- O.V. Kalennik
- G.V. Pavlova
- N.S. Samoilenkova
- E.A. Savchenko
- S.F. Drozd
- D.S. Lukash
Institutions
- Burdenko Neurosurgery Institute (RU)
- Institute of Higher Nervous Activity and Neurophysiology (RU)
Publication Details
- Journal
- Burdenko s Journal of Neurosurgery
- Published
- 2025-12-30
- DOI
- https://doi.org/10.17116/neiro20258906214
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00